Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RESPONSE DEPENDENT TREATMENT OF STAGES IA, IIA AND IIIA HODGKIN'S DISEASE WITH DBVE AND LOW DOSE INVOLVED FIELD IRRADIATION WITH OR WITHOUT ZINECARD: A PEDIATRIC ONCOLOGY GROUP PHASE III STUDY

NCT00002827 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00002827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RESPONSE DEPENDENT TREATMENT OF STAGES IA, IIA AND IIIA HODGKIN'S DISEASE WITH DBVE AND LOW DOSE INVOLVED FIELD IRRADIATION WITH OR WITHOUT ZINECARD: A PEDIATRIC ONCOLOGY GROUP PHASE III STUDY
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
October 31, 1996
Completion date
June 30, 2008
Enrollment
294 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac toxicity, lymphoma